PACIRA BIOSCIENCES IN
16.84
29-November-24 11:03:39
15 minutes delayed
Stocks
+0.20
+1.20%
Today's range
16.47 - 16.84
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
09 Jul 2024 09:45:29 By NetDania Notify
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
02 Jul 2024 09:54:55 By NetDania Notify
-
30 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
08 May 2024 16:05:14 By Nasdaq GlobeNewswire
-
07 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
07 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
30 Apr 2024 08:00:01 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
25 Apr 2024 09:45:09 By NetDania Notify
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
22 Apr 2024 11:49:23 By NetDania Notify
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
15 Apr 2024 11:02:15 By NetDania Notify
-
02 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
22 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 08:36:16 By Nasdaq GlobeNewswire
-
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
07 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
04 Jan 2024 17:00:41 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 08:00:01 By Nasdaq GlobeNewswire